The Nobel Committee in Physiology or Medicine awarded its prize not for a living patient, but for a long-dead cousin. On October 3, 2022, Swedish geneticist Svante Pääbo received the call for his work sequencing the Neanderthal genome. His team extracted DNA from 40,000-year-old bone fragments, a task once deemed impossible due to chemical degradation and microbial contamination. They built a clean room laboratory that became a time machine, isolating genetic whispers from ancient dust.
Pääbo’s work proved that Neanderthals were not a separate branch sheared from the human family tree. His data revealed that sequences of Neanderthal DNA persist in modern humans of European or Asian descent, the result of interbreeding. This genetic legacy is not merely historical trivia; it influences contemporary physiology, from immune response to susceptibility to severe COVID-19. The award recognized a fundamental shift: paleogenetics moved from speculative fiction to a rigorous historical science.
A common assumption holds that advanced Homo sapiens simply replaced other hominins. Pääbo’s genome corrected that narrative. It showed coexistence and interaction, a messy, intertwined process of migration and mixture. The prize also implicitly honored his other major discovery: the Denisovans, an entire hominin group identified solely from a finger bone’s DNA. He found a new species in a database.
The lasting impact is a new origin story, written in adenine, guanine, cytosine, and thymine. Medical researchers now routinely screen for Neanderthal gene variants when studying traits like pain sensitivity or depression. Pääbo’s techniques became the standard for ancient DNA work, applied to mammoths, extinct horses, and human ancestors. He provided the definitive evidence that our species was never alone.